Roche's price for Flatiron Health spread over the patient records on its oncology platform (whole-company acquisition, arithmetic over two stated numbers)
$1.9 billion
USD per patient record, US
“Under the deal, biotech leader Roche will buy Flatiron for $1.9 billion (1.6 billion euros) ... Flatiron says it runs a huge platform with over two million patient records available for research”
AFP via The Local, Roche seals takeover of cancer data upstart Flatiron (6 April 2018), 2018-04-06
- Kind of source
- Named press report
- Read on
- 2026-11-07
- Daily check
- Quote found at the source on 2026-11-06
- What to know
- A whole-company price: it also bought Flatiron's oncology EHR software, its provider network and its curation staff, and Roche already held 12.6 percent, so this is a high anchor and not a pure data price. The count is Flatiron's own claim ('over two million'), so the true price per record is somewhat lower; the closing price is the same USD 1.9 billion in Roche's own release of the same date.
- Arithmetic
- $1,900,000,000 / 2,000,000 patient records = $950 per record (the count is 'over two million', so this is an upper bound).